ABSTRACT
INTRODUCTION
Multiple sclerosis (MS) is an autoimmune inflammatory disease which results in demyelination of central ner-vous system cells. MS afflicts approximately 0.03 % of the world's population, and is particularly prevalent in populations of Northern European descent where the incidence has been estimated to be as high as 0.2 % of the population. 1 Furthermore, MS has been proposed to have a latitudinal correlation, with higher prevalence's in far northern regions of the Northern Hemisphere and far south of the Southern Hemisphere than in tropical regions. 2 It was proposed in that study that the latitudinal correlation may be linked to the increased incidence of respiratory infections at these latitudes. The disease onset is most predominant in young adults in their 20s and 30s and rarely begins in childhood or in people over 50. 3 As with several other autoimmune disorders including rheumatoid arthritis (RA), MS is significantly more common in women than in men. 3 Indeed, a recent study by the World Health Organization (WHO) estimates that MS is approximately twice as prevalent in women than in men. 4 Pathologically, MS is characterized by the formation of central nervous system (CNS) lesions (also called plaques), inflammation and widespread areas of demyelinated neurons. 1 Clinically, MS is characterized by a wide variety of neurological signs and symptoms with autonomic, motor and sensory affects being the most common. 5 The specific symptoms in each individual appear to be determined by the location of the lesions in the CNS and may include loss of sensitivity, a 'tingling' sensation (paresthesias, numbness), muscle weakness, spasms, uncoordinated movement, pronounced reflexes, vocal and speech problems, difficulty with swallowing, visual disturbances, chronic fatigue, sexual dysfunction, pain and heat intolerance.
1 Difficulty with cognitive reasoning and emotional issues (e.g. depression, unstable moods) are also common amongst MS sufferers. 5 The progression of MS is highly variable. The majority of patients initially present with isolated (relapsing) attacks, followed by complete or partial recovery from their symptoms. 6 In the relapse-remitting form of the disease (RRMS), individual attacks may be characterized by new symptoms or a recurrence of previously expressed symptoms. Alternatively, 10-15 % of MS patients accumulate neurological disabilities continuously from the disease etiology, without periods of remission.
There is currently no known cure for MS. Current treatment strategies using anti-inflammatory drugs aim to alleviate the symptoms. Administration of high doses of corticosteroids, whilst effective for short term relief, does not have a significant impact on long term recovery. 7 Furthermore, these pharmacological treatments are not ideal as prolonged usage of these drugs is often accompanied by significant side effects and toxicity. 8 Alternatively, MS may be controlled through complementary and alternative therapies including diet, yoga, acupuncture, hyperbaric oxygen therapy, reflexology 9 and herbal medicines (including cannabis), 9,10 with varied success. There is a need to find and develop safe, effective drugs for the treatment of MS which will not only alleviate the symptoms, but which may also prevent progression of the disease. Greater understanding of the disease's etiology and progression should allow more relevant drug discovery and development.
The causes of MS are currently not fully understood. It is generally accepted to be an autoimmune disorder which may be triggered by specific microbial infections in genetically susceptible individuals with specific antigenic sequences ( Table 1) . 11 There has been some conjecture as to the nature of the infection(s) and several infective agents have been proposed. However, the roles of most of these organisms in the pathogenic mechanisms that lead to MS have been ruled out as causative agents because of contradictory evidence. Recent studies have documented the presence of elevated serum levels of antibodies specific to Acinetobacter spp. and Pseudomonas aeruginosa in individuals suffering from MS. 11 Furthermore, amino acid sequence homologies have been identified between the' TRHAYG' and 'SRFAYG' sequence motifs present in the P. aeruginosa ϒ-carboxy-muconolactone decarboxylase (ϒ-CMLD) enzyme and them yelin-neuronal basic protein (MBP) 'SRFSYG'sequence present in susceptible individuals (Table 1) . [12] [13] [14] Further peptide similarities were also identified between the 'LTRAGK' motif in P. aeruginosa 3-oxoadipate CoA-transferase (3-OACT-A) and a'LYRDGK' myelin oligodendrocyte glycoprotein (MOG) amino acid sequence in susceptible individuals. A further sequence homology has also been detected between the KKVEEIsequences of both Acinetobacter spp. regulatory proteinand host neurofilament-M protein.
Many antibiotics are already known to inhibit Acinetobacter spp. and P. aeruginosa growth (e.g. amino glycosides, fluoroquinolones, tetracyclines, chloramphenicol). However, the development of super-resistant bacterial strains has reduced their value for treating many diseases. The search is ongoing for new antimicrobials, either by (a) the design and synthesis of new agents, or (b) re-searching the repertoire of natural resources for as yet unrecognised or poorly characterised antimicrobial agents.The antiseptic qualities of medicinal plants have long been recognised by many cultures. Recently there has been a revival of interest in herbal medications due to perceptions that there is often a lower incidence of adverse reactions to natural end biotic phytochemicals compared to synthetic xenobiotic pharmaceuticals.
Terminalia ferdinandiana is an endemic Australian plant which has been reported to have an extremely high antioxidant content. 15, 16 Furthermore, it was reported that the fruit of this plant also has the highest ascorbic acid levels of any plant in the world, with levels reported as high as 6% of the recorded wet weight. 17, 18 This is approximately 900 times higher (g/g) than the ascorbic acid content in blueberries (which were used as a standard). As a further comparison, oranges and grapefruit (which are considered good sources of ascorbic acid) only contain approximately 0.007% wet weight (0.5% dry weight).
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T. ferdinandiana has previously been shown to have strong antibacterial activity against an extensive panel of bacteria. 20 Solvent extracts of various polarities were tested against both Gram positive and Gram negative bacteria. The polar extracts proved to be more effective antibacterial agents, indicating that the antibacterial components were polar. Indeed, the polar extracts inhibited the growth of nearly every bacteria tested. Both Gram positive and Gram negative bacteria were susceptible, indicating that the inhibitory compounds may readily cross the Gram negative cell wall.
Recently, T. ferdinandiana leaf extracts were shown to have potent inhibitory activity against the bacterial triggers of several auto immune inflammatory diseases including multiple sclerosis. 21 That study indicated that the inhibition of the bacterial triggers of multiple sclerosis by the leaf extracts may be due to their high tannin content. Despite this, and the extremely high antioxidant capacity of T. ferdinandiana fruit, the fruit extracts have not been evaluated for the ability to inhibit Acinetobacter spp. and P. aeruginosa growth, nor has the phytochemistry of these extracts been extensively examined. The current study was undertaken to test the ability of T. ferdinandiana fruit extracts to inhibit the growth of bacteria associated with multiple sclerosis etiology and to determine if the fruit extracts have similar phytochemical compositions to the leaf extracts.
MATERIALS AND METHODS

T. ferdinandiana fruit pulp samples
T. ferdinandiana fruit pulp was a gift from David Boehme of Wild Harvest, Northern Territory, Australia. The pulp was frozen for transport and stored at -10 o C until processed.
Preparation of extracts
T. ferdinandiana fruit pulp was thawed at room temperature and dried in a Sunbeam food dehydrator. The dried pulp material was subsequently ground to a coarse powder. A mass of 1 g of ground dried pulp was extracted extensively in 50 ml of methanol, deionised water, ethyl acetate, chloroform or hexane for 24 hours at 4 o C with gentle shaking. All solvents were supplied by Ajax and were AR grade. The extracts were filtered through filter paper (Whatman No. 54). The solvent extracts were air dried at room temperature. The aqueous extract was lyophilised by rotary evaporation in an Eppendorf concentrator 5301. The resultant pellets were dissolved in 10 ml deionised water (containing 0.5% DMSO). The extract was passed through 0.22 µm filter (Sarstedt) and stored at 4 o C.
Qualitative phytochemical studies
Phytochemical analysis of the T. stipitata extracts for the presence of saponins, phenolic compounds, flavonoids, polysteroids, triterpenoids, cardiac glycosides, anthraquinones, tannins and alkaloids was conducted by previously described assays.
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Antioxidant capacity
The antioxidant capacity of each sample was assessed using the DPPH free radical scavenging method 25 with modifications. Briefly, DPPH solution was prepared fresh each day as a 400 µM solution by dissolving DPPH (Sigma) in AR grade methanol (Ajax, Australia). The initial absorbance of the DPPH solution was measured at 515 nm using a Molecular Devices, Spectra Max M3 plate reader and did not change significantly throughout the assay period. A 2 ml aliquot of each extract was evaporated and the residue resuspended in 2 ml of methanol. Each extract was added to a 96-well plate in amounts of 5, 10, 25, 50, 75 µl in triplicate. Methanol was added to each well to give a volume of 225 µl. A volume of 75 µl of the fresh DPPH solution was added to each well for a total reaction volume of 300 µl. A blank of each extract concentration, methanol solvent, and DPPH was also performed in triplicate. Ascorbic acid was prepared fresh and examined across the range 0-25 µg per well as a reference and the absorbance's were recorded at 515. All tests were performed in triplicate and triplicate controls were included on each plate. The antioxidant capacity based on DPPH free radical scavenging ability was determined for each extract and expressed as µg ascorbic acid equivalents per gram of original plant material extracted.
Antibacterial screening
Test microorganisms
All media was supplied by Oxoid Ltd. Reference strains of Acinetobacter baylyi (ATCC33304) and Pseudomonas aeruginosa (ATCC39324) were purchased from American Tissue Culture Collection, USA. Clinical strains of these microbial species were obtained from the School of Natural Sciences teaching laboratory, Griffith University. All stock cultures were subcultured and maintained in nutrient broth at 4 o C.
Evaluation of antimicrobial activity
Antimicrobial activity of all plant extracts was determined using a modified disc diffusion assay. [26] [27] [28] [29] Briefly, 100 µl of the test bacteria were grown in 10 ml of fresh nutrient broth media until they reached a count of approximately 10 8 cells/ml. An amount of 100 µl of bacterial suspension was spread onto nutrient agar plates. The extracts were tested for antibacterial activity using 5 mm sterilised filter paper discs. Discs were impregnated with 10 µl of the test sample, allowed to dry and placed onto inoculated plates. The plates were allowed to stand at 4 o C for 2 hours before incubation with the test microbial agents. Plates inoculated with Pseudomonas aeuroginosa, were incubated at 30 o C for 24 hours, then the diameters of the inhibition zones were measured in millimetres. Plates inoculated with Acinetobacter baylyi, were incubated at 37 o C for 24 hours, then the diameters of the inhibition zones were measured. All measurements were to the closest whole millimetre. Each antimicrobial assay was performed in at least triplicate. Mean values (± SEM) are reported in this study. Standard discs of ampicillin (2 µg) and chloramphenicol (10 µg) were obtained from Oxoid Ltd. and served as positive controls for antibacterial activity. Filter discs impregnated with 10 µl of distilled water were used as a negative control.
Minimum inhibitory concentration (MIC) determination
The minimum inhibitory concentration (MIC) of the extracts were determined as previously described. 30, 31 Briefly, the plant extracts were diluted in deionised water and tested across a range of concentrations. Discs were impregnated with 10 µl of the test dilutions, allowed to dry and placed onto inoculated plates. The assay was performed as outlined above and graphs of the zone of inhibition versus concentration were plotted for each extract. Linear regression was used to calculate the MIC values.
Toxicity screening
Reference toxin for toxicity screening
Potassium dichromate (K 2 Cr 2 O 7 ) (AR grade, Chem-Supply, Australia) was prepared as a 1.6 mg/ml solution in distilled water and was serially diluted in artificial seawater for use in the Artemia franciscana nauplii bioassay.
Artemia franciscana nauplii toxicity screening
Toxicity was tested using a modified Artemia franciscana nauplii lethality assay. [32] [33] [34] Briefly, 400 µl of seawater containing approximately 43 (mean 43.2, n=155, SD 14.5) A. franciscana nauplii were added to wells of a 48 well plate and immediately used for bioassay. A volume of 400 µl of diluted plant extracts or the reference toxin were transferred to the wells and incubated at 25 ± 1 o C under artificial light (1000 Lux). A negative control (400 µl seawater) was run in triplicate for each plate. All treatments were performed in at least triplicate. The wells were checked at regular intervals and the number of dead counted. The nauplii were considered dead if no movement of the appendages was observed within 10 seconds. After 72 h all nauplii were sacrificed and counted to determine the total % mortality per well. The LC50 with 95% confidence limits for each treatment was calculated using probit analysis.
Non-targeted HPLC-MS QTOF analysis
Chromatographic separations were performed as previously described. 21, 25 Briefly, 2 µL of sample was injected onto an Agilent 1290 HPLC system fitted with a Zorbax Eclipse plus C18 column (2.1 x 100 mm, 1.8 µm particle size). The mobile phases consisted of (A) ultrapure water and (B) 95:5 acetonitrile/water at a flow rate of 0.7 mL/min. Both mobile phases were modified with 0.1% (v/v) glacial acetic acid for mass spectrometry analysis in positive mode and with 5 mM ammonium acetate for analysis in negative mode. The chromatographic conditions utilised for the study consisted of the first 5 min run isocratically at 5% B, a gradient of (B) from 5% to 100% was applied from 5 min to 30 min, followed by 3 min isocratically at 100%. Mass spectrometry analysis was performed on an Agilent 6530 quadrapole time-of-flight spectrometer fitted with a Jetstream electrospray ionisation source in both positive and negative mode.
Data was analysed using the Mass hunter Qualitative analysis software package (Agilent Technologies). Blanks using each of the solvent extraction systems were analysed using the Find by Molecular Feature algorithm in the software package to generate a compound list of molecules with abundances greater than 10,000 counts. This was then used as an exclusion list to eliminate background contaminant compounds from the analysis of the extracts. Each extract was then analysed using the same parameters using the Find by Molecular Feature function to generate a putative list of compounds in the extracts. Compound lists were then screened against three accurate mass databases; a database of known plant compounds of therapeutic importance generated specifically for this study (800 compounds); the Metlin metabolomics database (24,768 compounds); and the Forensic Toxicology Database by Agilent Technologies (7,509 compounds). Empirical formula for unidentified compounds was determined using the Find Formula function in the software package.
Non-targeted GC-MS head space analysis
Separation and quantification were performed with a Shimadzu GC-2010 plus (USA) linked to a Shimadzu MS TQ8040 (USA) mass selective detector system. The system was equipped with a Shimadzu auto-sampler AOC-5000 plus (USA) fitted with a solid phase micro-extraction fibre (SPME) handling system utilising a Supelco (USA) divinyl benzene/carbowax/polydimethylsiloxane (DVB/CAR/ PDMS). Chromatographic separation was accomplished using a 5% phenyl, 95% dimethylpolysiloxane (30 m x0.25 mm id x 0.25 um) capillary column (Restek USA). Helium (99.999%) was employed as a carrier gas at a flow rate of 0.79 ml/min. The injector temperature was set at 230°C. Sampling utilised a SPME cycle which consisted of an agitation phase at 500 rpm for a period of 5 sec. The fibre was exposed to the sample for 10 mins to allow for absorption and then desorbed in the injection port for 1 min at 250°C. The initial column temperature was held at 30°C for 2 min, increased to 140°C for 5 min, then increased to 270°C over a period of 3 mins and held at that temperature for the duration of the analysis. The GC-MS interface was maintained at 200°C with no signal acquired for a min after injection in split less mode. The mass spectrometer was operated in the electron ionisation mode at 70 eV. The analytes were then recorded in total ion count (TIC) mode. The TIC was acquired after a min and for duration of 45 mins utilising a mass range of 45 -450 m/z. 
Water insoluble phenolics
+++ +++ + - - Cardiac glycosides - - - - - Saponins ++ + + - - Triterpenes + - ++ - - Polysteroids - - - - - Alkaloids Meyer test + - - - - Wagner test + - - - - Flavonoids +++ +++ ++ - - Tannins ++ ++ - - - Anthraquinones Free - - - - - Combined - - - - - Antioxidant
Statistical analysis
Data are expressed as the mean ± SEM of at least three independent experiments.
RESULTS
Liquid extraction yields and qualitative phytochemical screening
Extraction of 1 g of dried T. ferdinandiana fruit with various solvents yielded dried plant extracts ranging from 30 mg (ethyl acetate extract) to 483 mg (water extract) ( Table 2) . Deionised water and methanol gave relatively high yields of dried extracted material, whilst all other solvents extracted lower masses. The dried extracts were resuspended in 10 ml of deionised water resulting in the extract concentrations shown in Table 2 .
Qualitative phytochemical studies (Table 2) showed that methanol and water extracted the widest range of phytochemicals. Both showed high levels of phenolics (both water soluble and insoluble phenolics) and flavonoids, as well as high to moderate to high levels of tannins. Saponins were also present in low to moderate levels. Triterpenes and alkaloids were also present in low levels in the methanol extract. The ethyl acetate extract also had moderate lev- els of phenolics, flavonoids and triterpenes as well as low levels of saponins. Low levels of phenolics were detected in the chloroform extract whilst no phytochemical class was present in detectable levels in the hexane extract.
Antioxidant content
Antioxidant capacity (expressed as ascorbic acid equivalence) for the T. ferdinandiana fruit extracts are shown in Table 2 . The antioxidant capacity ranged from a low of 1 mg ascorbic acid equivalence per gram of dried plant material extracted (hexane extract) to a high of 660 mg ascorbic acid equivalence per gram of dried plant material extracted (methanol extract). Whilst significantly lower than the methanol extract, the aqueous extract also had high antioxidant capacity with 264 mg ascorbic acid equivalence per gram of dried plant material extracted.
Antimicrobial activity
To determine the antimicrobial activity of the crude plant extracts, aliquots (10 µL) of each extract were tested in the disc diffusion assay against a panel of bacteria previously identified as microbial triggers of autoimmune inflammatory diseases. Both reference and clinical strains of Acinetobacter baylyi were strongly inhibited by the methanol, water and ethyl acetate T. ferdinandiana fruit extracts (Figure 1) . Indeed, all 3 of these extracts inhibited A.baylyi growth of both strains more effectively than the ampicillin and chloramphenicol controls, with zones of inhibition generally>10 mm for against both strains (compared to < 8 mm for the ampicillin and chloramphenicol controls). The A. baylyi reference strain was significantly more susceptible to the methanol and ethyl acetate extracts than was the clinical strain (as determined by the zones of inhibition) (Figure 1 ). The methanol extract was the most potent bac- terial growth inhibitor, with zones of inhibition of 14.1 and 12.6 mm for the reference and clinical strains respectively. The ethyl acetate extract was also a potent inhibitor of the reference strain of A. baylyi growth with zones of inhibition of 12 and 8.9 mm for the reference and clinical strains respectively. In contrast, the clinical strain was significantly more susceptible to the aqueous extract than was the reference strain (12.2 and 8.2 mm respectively). Neither the chloroform nor the hexane extract displayed any inhibitory activity against either A. baylyi strain.
P. aeruginosa growth was also susceptible to the methanol, water and ethyl acetate extracts, albeit to a lesser extent ( Figure 2 ). The clinical strain was significantly more susceptible to these extracts than was the reference strain. Zones of inhibition of 12.0, 8.6 and 8.3 mm were noted for the clinical P. aeruginosa strain against the methanol, water and ethyl acetate extracts respectively. In contrast, the zones of inhibition for these extracts against the reference strain were approximately 8.2, 6.9 and 7.3 mm respectively.
The antimicrobial efficacy was further quantified by determining the MIC values for each extract against the microbial species/strains which were determined to be susceptible (Table 3) . Most of the extracts were effective at inhibiting microbial growth, with MIC values against the susceptible bacteria generally <1000 µg/mL (<10 µg impregnated in the disc), indicating the potential of these extracts in inhibiting the microbial triggers ofmultiple sclerosis and limiting its impact.
Quantification of toxicity
T. ferdinandia fruit extracts were initially screened at 2000 µg/mL in the assay (Figure 3 ). For comparison, the reference toxin potassium dichromate (1000 µg/mL) was also tested in the bioassay. The potassium dichromate reference toxin was rapid in its onset of mortality, inducing mortality within the first 3 hours of exposure and 100 % mortality was evident following 4-5 hours (unpublished results).The methanol and water extracts also induced significant mortality following 24 h exposure, indicating that they were toxic at the concentration tested. The ethyl acetate, chloroform and hexane extracts did not induce mortality significantly different to the seawater control and were therefore deemed to be nontoxic. To further quantify the effect of toxin concentration on the induction of mortality, the extracts were serially diluted in artificial sea water to test across a range of concentrations in the Artemia nauplii bioassay at 24 hours. Table 3 shows the LC50 values of the T. ferdianadiana fruit extracts towards A. franciscana. No LC50 values are reported for the ethyl acetate, chloroform and hexane extracts as less than 50 % mortality was seen for all concentrations tested. Extracts with an LC50 greater than 1000 µg/mL towards Artemia nauplii have been defined as being nontoxic in this assay. 35 As none of the extracts had a LC50 <1000 µg/mL, all were considered nontoxic.
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HPLC-MS QTOF analysis
As the ethyl acetate extract had the greatest antibacterial efficacy (as determined by MIC) yet contained a low mass of extracted material (Table 1) , it was deemed the most promising extract for further phytochemical analysis. Optimised HPLC-MS QTOF parameters used previously for the analysis of T. ferdinandiana leaf extracts 21 were also used to determine the ethyl acetate fruit extract compound profile in this study. The resultant total compound chromatograms for the positive ion and negative ion chromatograms are presented in Figure 4a and 4b respectively. The negative ion chromatograms had significantly higher background absorbance levels than the positive ion chromatogram, due to ionisation of the reference ions in this mode, possibly masking the signal for some peaks of interest.
The T. ferdinandiana ethyl acetate extract positive ion base peak chromatogram (Figure 4a ) revealed several overlapping peaks in the early stages of the chromatogram corresponding to the elution of polar compounds. Most of the extract compounds had eluted in the first couple of minutes during the isocratic stage of the chromatogram (5 % acetonitrile). However, several prominent peaks in the positive ionisation mode chromatogram between 11 and 16 min indicates the broad spread of polarities of the compounds in this extract.
In total, 42 unique mass signals were noted for the T. ferdinandiana fruit ethyl acetate extract (Table 4) . Putative empirical formulas were achieved for all of these compounds. Of the 42 unique molecular mass signals detected, 31 compounds (73.8 %) were putatively identified by comparison to the Metlin metabolomics, forensic toxicology (Agilent) and phytochemicals (developed in this laboratory) databases.
GC-MS Head space analysis
Optimised GC-MS parameters were developed and used to further examine the ethyl acetate fruit extract compound profile. The resultant gas chromategram is presented in Figure 5 . Several major peaks were noted at approximately 15.7, 18.0, 19.7, 21.4 and 22.7 min. numerous overlapping peaks were also evident in all stages of the chromate gram. In total, 140 unique mass signals were noted for the T. ferdinandiana fruit ethyl acetate extract (Table 5) . Putative empirical formulas and identifications were achieved for all of these compounds.
DISCUSSION
Previous studies within our laboratory reported potent antibacterial activity for T. ferdianadiana fruit extracts (Cock and Mohanty 2011) . Recently, we also reported growth inhibitory activity of T. ferdianadiana leaf extracts against some microbial triggers of selected autoimmune inflam- dried and resuspended in methanol. Chromatography conditions were as described in the methods section. In contrast to the previous leaf study, only 2 tannin compound (gallic acid (Figure 6a ) and chebulic acid (Figure 6b)) were detected in the T. ferdianadiana fruit extracts by LC-MS analysis. Whilst both of these tannins have been reported to be potent antibacterial agents (Cock 2013) they were detected at much lower relative levels than in the leaf extracts (Courtney et al. in press ).
The fruit extracts examined in this study displayed potent growth inhibitory activity against A. baylyi and P. aeruginosa. MIC values <1000 µg/ml are reported for the fruit ethyl acetate extract against all bacterial triggers of MS tested (A. baylyi and P. aeruginosa reference and clinical strains). In our previous study screening T. ferdianadiana leaf extracts, lower MIC values were noted against A. baylyi than are reported here for the fruit extracts, indicating the greater potency of the leaf ethyl acetate extract against these bacteria. In contrast, the lower MIC values towards the P. aeruginosa determined for the T. ferdianadiana fruit extracts in this study compared to the leaf extracts in the previous study indicate that these 2 bacterial species may be inhibited via different mechanisms.
As much lower tannin amounts and diversity were detected in the T. ferdianadiana fruit ethyl acetate extract compared to the leaf extract, is likely that other phytochemical classes may contribute to the anti-inflammatory properties of these extracts. Alkaloids, anthraquionones, flavonoids, polyphenolics, phytosterols, saponins, stilbenes and terpenes have also been linked with antibacterial activity in different plant species and thus may be responsible (at least in part) for the bacterial growth inhibitory activities reported here.
An important consideration of any metabolomic technique is that it will not detect all compounds in a complex mixture, but instead will only detect a portion of them. This is not necessarily a problem when a directed/biased study is undertaken to detect a particular compound or class of compounds and the separation and detection conditions can be optimised for the study. However, when the aim of the study is metabolomic profiling rather than metabolomic fingerprinting, the technique conditions must be chosen and optimised to separate and detect the largest amount of compounds, with the broadest possible physical and chemical characteristics. Generally, HPLC-MS is a good choice for such metabolomic profiling studies as it generally detects a larger amount of compounds of varying polarities than the other commonly used techniques. However, this method is limited to studies of the mid-highly polar compounds and is not as useful for studies aimed at highly non-polar compounds. Thus, many nonpolar phytosterols, saponins, stilbenes and terpenes which may contribute to the inhibitory activity of the ethyl acetate extract may escape detection by HPLC-MS. For this reason, we also utilised GC-MS analysis to detect many of the less polar compounds. This enabled us to obtain the broadest possible metabolomic profile of the bioactive extract.
A number of monoterpenoids including isomyocorene (Figure 6c ), cineole (eucalyptol) (Figure 6d ), cuminol (Figure 6e ), camphor ( Figure 6f ) and isomenthol ( Figure  6g) were detected in the ethyl acetate fruit extract by GC-MS analysis. The amyrintriterpenoid (3β,4α,16α,21β, 22α) Olean-12-ene-3, 16, 21, 22, 23, 28-hexol ( Figure  6 h) was also detected by GC-MS. Many of these terpenoids have been previously reported to have potent broad spectrum antibacterial activity 41 and therefore may contribute to the inhibitory activity against A. baylyi and P. aeruginosa in our study. Interestingly, several of these monoterpenes have also been reported to suppress NF-κB signalling (the major regulator of inflammatory diseases). [42] [43] [44] [45] Thus, the terpene components may have a pleuripotent mechanism in blocking multiple sclerosis and relieving its symptoms by acting on both the initiator and downstream inflammatory stages of the disease. Figure  6m ) were also putatively identified in our study. Many studies have reported potent antibacterial activities for a wide variety of flavonoids. 46 Thus, it is likely that multiple compounds within the ethyl acetate extract are contributing to the growth inhibition of the microbial triggers of MS. The putative identification of rebamipidine is particularly interesting as it has also been reported to suppress bladder 47 and gastrointestinal inflammation.
48
The propionic acid derivative carpofen (Figure 6n ) also has anti-inflammatory properties and has been reported to inhibit cyclooxygenase 2 (COX-2) and thus block the synthesis of pro-inflammatory prostaglandins.
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Whilst our studies provide insight into the phytochemical composition of this extract, it is noteworthy that mass spectral techniques are generally not capable on their own of differentiating between structural isomers. Further studies using a wider variety of techniques are required to confirm the identity of the compounds putatively identified here. Our findings demonstrate that T. Ferdinandiana fruit extracts display low toxicity towards Artemia franciscana. Indeed, the LC50 values for all extracts were well in excess of 1000 µg/ml and are therefore nontoxic.
CONCLUSION
The results of this study demonstrate the potential of T. Ferdianadiana fruit extracts to block the growth of bacterial species associated with the onset of MS. Thus, T. Ferdianadiana fruit extracts have potential in the prevention and treatment of MS in genetically susceptible individuals. Further studies aimed at the purification and identification of the bioactive components are needed to examine the mechanisms of action of these agents.
